Most Recent
Women who were allegedly injured by defective pelvic mesh implants can apply to set aside two approved settlements against Johnson & Johnson and Boston Scientific worth $405 million.
A judge has approved a $56 million settlement in a class action alleging Monash IVF destroyed potentially viable embryos, including a $10.6 million payout for the firm that ran the case.
Johnson & Johnson has been hit with a class action for allegedly pushing ineffective cold and flu medications containing phenylephrine onto customers for decades.
A class action against Toyota Finance has argued it can add new claims that are out of time because Victorian courts cannot factor in the loss of limitations defences in deciding whether to allow amendments.
Graincorp may face new allegations in a class action that the use of n-Hexane at an oilseed factory in rural Victoria had an impact on the health of local residents.
A judge has given the green light to a $31.5 million settlement in a class action brought by junior doctors accusing the ACT government and North Canberra Hospital of failing to pay overtime.
A judge has approved a $57.5 million settlement in a class action against ANZ over credit card interest, including allowing the funder to recoup $1.2 million in after-the-event insurance costs.
An investor class action against failed advisory firm Linchpin Capital and its former directors has won its bid to claim its losses against a $10 million insurance policy from AIG.
A judge has set a final deadline for the CEO of International Capital Markets to file his defence in a class action over risky contracts for difference.
Boral has won a legal challenge to its former CEO facing cross-examination in a shareholder class action trial over an email referring to a confidential EY report.